解开人类肠道微生物群的秘密:对其在不同疾病中的作用的综合综述。

IF 7.7 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY World Journal of Gastroenterology Pub Date : 2025-02-07 DOI:10.3748/wjg.v31.i5.99913
Jibon Kumar Paul, Mahir Azmal, Anm Shah Newaz Been Haque, Meghla Meem, Omar Faruk Talukder, Ajit Ghosh
{"title":"解开人类肠道微生物群的秘密:对其在不同疾病中的作用的综合综述。","authors":"Jibon Kumar Paul, Mahir Azmal, Anm Shah Newaz Been Haque, Meghla Meem, Omar Faruk Talukder, Ajit Ghosh","doi":"10.3748/wjg.v31.i5.99913","DOIUrl":null,"url":null,"abstract":"<p><p>The human gut microbiota, a complex and diverse community of microorganisms, plays a crucial role in maintaining overall health by influencing various physiological processes, including digestion, immune function, and disease susceptibility. The balance between beneficial and harmful bacteria is essential for health, with dysbiosis - disruption of this balance - linked to numerous conditions such as metabolic disorders, autoimmune diseases, and cancers. This review highlights key genera such as <i>Enterococcus</i>, <i>Ruminococcus</i>, <i>Bacteroides</i>, <i>Bifidobacterium</i>, <i>Escherichia coli</i>, <i>Akkermansia muciniphila</i>, <i>Firmicutes</i> (including <i>Clostridium</i> and <i>Lactobacillus</i>), and <i>Roseburia</i> due to their well-established roles in immune regulation and metabolic processes, but other bacteria, including <i>Clostridioides difficile</i>, <i>Salmonella</i>, <i>Helicobacter pylori</i>, and <i>Fusobacterium nucleatum</i>, are also implicated in dysbiosis and various diseases. Pathogenic bacteria, including <i>Escherichia coli</i> and <i>Bacteroides fragilis</i>, contribute to inflammation and cancer progression by disrupting immune responses and damaging tissues. The potential for microbiota-based therapies, such as probiotics, prebiotics, fecal microbiota transplantation, and dietary interventions, to improve health outcomes is examined. Future research directions in the integration of multi-omics, the impact of diet and lifestyle on microbiota composition, and advancing microbiota engineering techniques are also discussed. Understanding the gut microbiota's role in health and disease is essential for formulating personalized, efficacious treatments and preventive strategies, thereby enhancing health outcomes and progressing microbiome research.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"31 5","pages":"99913"},"PeriodicalIF":7.7000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718612/pdf/","citationCount":"0","resultStr":"{\"title\":\"Unlocking the secrets of the human gut microbiota: Comprehensive review on its role in different diseases.\",\"authors\":\"Jibon Kumar Paul, Mahir Azmal, Anm Shah Newaz Been Haque, Meghla Meem, Omar Faruk Talukder, Ajit Ghosh\",\"doi\":\"10.3748/wjg.v31.i5.99913\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The human gut microbiota, a complex and diverse community of microorganisms, plays a crucial role in maintaining overall health by influencing various physiological processes, including digestion, immune function, and disease susceptibility. The balance between beneficial and harmful bacteria is essential for health, with dysbiosis - disruption of this balance - linked to numerous conditions such as metabolic disorders, autoimmune diseases, and cancers. This review highlights key genera such as <i>Enterococcus</i>, <i>Ruminococcus</i>, <i>Bacteroides</i>, <i>Bifidobacterium</i>, <i>Escherichia coli</i>, <i>Akkermansia muciniphila</i>, <i>Firmicutes</i> (including <i>Clostridium</i> and <i>Lactobacillus</i>), and <i>Roseburia</i> due to their well-established roles in immune regulation and metabolic processes, but other bacteria, including <i>Clostridioides difficile</i>, <i>Salmonella</i>, <i>Helicobacter pylori</i>, and <i>Fusobacterium nucleatum</i>, are also implicated in dysbiosis and various diseases. Pathogenic bacteria, including <i>Escherichia coli</i> and <i>Bacteroides fragilis</i>, contribute to inflammation and cancer progression by disrupting immune responses and damaging tissues. The potential for microbiota-based therapies, such as probiotics, prebiotics, fecal microbiota transplantation, and dietary interventions, to improve health outcomes is examined. Future research directions in the integration of multi-omics, the impact of diet and lifestyle on microbiota composition, and advancing microbiota engineering techniques are also discussed. Understanding the gut microbiota's role in health and disease is essential for formulating personalized, efficacious treatments and preventive strategies, thereby enhancing health outcomes and progressing microbiome research.</p>\",\"PeriodicalId\":23778,\"journal\":{\"name\":\"World Journal of Gastroenterology\",\"volume\":\"31 5\",\"pages\":\"99913\"},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2025-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718612/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3748/wjg.v31.i5.99913\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3748/wjg.v31.i5.99913","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

人类肠道微生物群是一个复杂而多样的微生物群落,通过影响消化、免疫功能和疾病易感性等各种生理过程,在维持整体健康方面发挥着至关重要的作用。有益细菌和有害细菌之间的平衡对健康至关重要,而生态失调——这种平衡的破坏——与代谢紊乱、自身免疫性疾病和癌症等许多疾病有关。这篇综述重点介绍了肠球菌、瘤胃球菌、拟杆菌、双歧杆菌、大肠杆菌、嗜粘杆菌、厚壁菌门(包括梭状芽胞杆菌和乳杆菌)和玫瑰杆菌等关键菌属,因为它们在免疫调节和代谢过程中发挥着重要作用,但其他细菌,包括艰难梭状芽胞杆菌、沙门氏菌、幽门螺杆菌和核梭杆菌,也与生态失调和各种疾病有关。致病菌,包括大肠杆菌和脆弱拟杆菌,通过破坏免疫反应和破坏组织,促进炎症和癌症进展。研究了基于微生物群的治疗方法,如益生菌、益生元、粪便微生物群移植和饮食干预,以改善健康结果的潜力。展望了今后的研究方向,包括多组学的整合、饮食和生活方式对微生物群组成的影响以及微生物群工程技术的发展。了解肠道微生物群在健康和疾病中的作用对于制定个性化、有效的治疗和预防策略至关重要,从而提高健康结果和推进微生物组研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Unlocking the secrets of the human gut microbiota: Comprehensive review on its role in different diseases.

The human gut microbiota, a complex and diverse community of microorganisms, plays a crucial role in maintaining overall health by influencing various physiological processes, including digestion, immune function, and disease susceptibility. The balance between beneficial and harmful bacteria is essential for health, with dysbiosis - disruption of this balance - linked to numerous conditions such as metabolic disorders, autoimmune diseases, and cancers. This review highlights key genera such as Enterococcus, Ruminococcus, Bacteroides, Bifidobacterium, Escherichia coli, Akkermansia muciniphila, Firmicutes (including Clostridium and Lactobacillus), and Roseburia due to their well-established roles in immune regulation and metabolic processes, but other bacteria, including Clostridioides difficile, Salmonella, Helicobacter pylori, and Fusobacterium nucleatum, are also implicated in dysbiosis and various diseases. Pathogenic bacteria, including Escherichia coli and Bacteroides fragilis, contribute to inflammation and cancer progression by disrupting immune responses and damaging tissues. The potential for microbiota-based therapies, such as probiotics, prebiotics, fecal microbiota transplantation, and dietary interventions, to improve health outcomes is examined. Future research directions in the integration of multi-omics, the impact of diet and lifestyle on microbiota composition, and advancing microbiota engineering techniques are also discussed. Understanding the gut microbiota's role in health and disease is essential for formulating personalized, efficacious treatments and preventive strategies, thereby enhancing health outcomes and progressing microbiome research.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
World Journal of Gastroenterology
World Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
7.80
自引率
4.70%
发文量
464
审稿时长
2.4 months
期刊介绍: The primary aims of the WJG are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastroenterology and hepatology.
期刊最新文献
Influence of blood transfusion on outcomes in patients with gastric cancer. Correction to "Metadherin promotes stem cell phenotypes and correlated with immune infiltration in hepatocellular carcinoma". Distribution and prognostic value of macrophages in colorectal cancer and adjacent mucosa in patient stages I-III vs IV. Gut bacterial and fungal signatures in relation to human leukocyte antigen-DQ2/DQ8 in children with celiac disease and siblings. Growth differentiation factor 11 reprograms M2-like macrophages: Targeting immunometabolism for cancer therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1